Table 3 Surgery results

From: Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)

Variable

Overall (N = 69)

n

(%)

Operability

  No

6

8.7

  Yes

57

82.6

  NE

6

8.7

Resection

  R0

42

60.9

  R1

14

20.3

  NE

13

18.8

Pathologic complete response

  No

34

49.3

  Yes

20

29.0

  No R0/R1 resected

13

18.8

  Missing

2

2.9

Back to article page